Endologix Announces 2007 First Quarter Financial Results Conference Call
April 19 2007 - 4:00AM
Business Wire
Endologix, Inc. (Nasdaq:ELGX), the developer of the Powerlink�
System for the minimally invasive treatment of abdominal aortic
aneurysms (AAA), today announced that the Company will hold a
conference call to discuss 2007 first quarter financial results on
Thursday, April 26, 2007, at 5:00 p.m. Eastern time (2:00 p.m.
Pacific time). Individuals interested in listening to the live
conference call may do so by dialing (888) 463-4487 toll free
within the U.S. and Canada, or (706) 634-5615 for international
callers. A telephone replay of the conference call will be
available for 48 hours beginning April 26 within two hours after
the conclusion of the call, by dialing (800) 642-1687 domestically
or (706) 645-9291 internationally, and entering reservation number
5519157. The conference call can be heard live via audio webcast at
the Company�s Web site: www.endologix.com. Please go to the
Interviews/Presentations page on the Investor Relations section of
the Web site. A replay will also be available for 14 days. About
Endologix Endologix, Inc. develops and manufactures minimally
invasive treatments for vascular diseases. Endologix�s Powerlink
System is an endoluminal stent graft (ELG) for treating abdominal
aortic aneurysms (AAA). AAA is a weakening of the wall of the
aorta, the largest artery in the body, resulting in a balloon-like
enlargement. Once AAA develops, it continues to enlarge and, if
left untreated, becomes increasingly susceptible to rupture. The
overall patient mortality rate for ruptured AAA is approximately
75%, making it the thirteenth leading cause of death in the U.S. In
October 2004, Endologix received approval to market the Powerlink
in the U.S. Additional information can be found on Endologix�s Web
site at www.endologix.com.
Endologix (NASDAQ:ELGX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Endologix (NASDAQ:ELGX)
Historical Stock Chart
From Jul 2023 to Jul 2024